Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Non-Hodgkin 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 62Tacrolimus 52Methotrexate 39Mycophenolic Acid 36Busulfan 35fludarabine phosphate 34Cyclosporine 32Antilymphocyte Serum 32fludarabine 28Sirolimus 23Peripheral Blood Stem Cell Transplantation 22Melphalan 22Radiotherapy 21Methylprednisolone 20Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 10Stem Cell Transplantation 9Granulocyte Colony-Stimulating Factor 9Hematopoietic Stem Cell Transplantation 7Cord Blood Stem Cell Transplantation 7ruxolitinib 6Rituximab 6Etoposide 6Transplantation 5Therapeutics 5Prednisone 5Flow Cytometry 5Cytarabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × milatuzumab × Other hematologic neoplasm × Clear all
NCT01663766 2021-08-19

Phase I Study of Milatuzumab for Graft Versus Host Disease

Gilead Sciences

Phase 1 Terminated
12 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡